TALPHERA, INC.
Develops therapies for acute pain and anticoagulants for medically supervised settings.
TLPH | US
Overview
Corporate Details
- ISIN(s):
- US00444T2096 (+1 more)
- LEI:
- Country:
- United States of America
- Address:
- 1850 GATEWAY DRIVE, 94404 SAN MATEO
- Website:
- https://talphera.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Talphera, Inc., formerly AcelRx Pharmaceuticals, is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings. The company's mission is to provide healthcare providers with tools to improve patient outcomes. Its product pipeline centers on treatments for acute pain and includes development-stage assets such as nafamostat-based anticoagulants and pre-filled syringes. The company officially rebranded from AcelRx to Talphera in January 2024.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all TALPHERA, INC. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for TALPHERA, INC.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for TALPHERA, INC. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
/other/Diamyd_Medical_AB_publ-logo.png){kind=logo}
